These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6957097)

  • 1. Observations on the development of dysplasia.
    Heinzl S; Szalmay G; Jochum L; Roemer V
    Acta Cytol; 1982; 26(4):453-6. PubMed ID: 6957097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smear biopsies: a cause of negative follow-up biopsies in patients with premalignant conditions of the uterine cervix.
    Berner A; Høeg K; Oppedal BR
    Diagn Gynecol Obstet; 1980; 2(2):99-101. PubMed ID: 7439010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
    Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
    Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term follow-up of women with first-time diagnosis of mild dysplasia detected by cytological examination of the cervix].
    Knudsen A; Nielsen K; Sandahl P; Andersen ES
    Ugeskr Laeger; 2003 May; 165(21):2183-7. PubMed ID: 12820504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological behaviour of moderate dysplasia--a prospective study.
    Murthy NS; Sardana S; Narang N; Agarwal SS; Sharma S; Das DK
    Indian J Cancer; 1996 Mar; 33(1):24-30. PubMed ID: 9063015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of 189 women diagnosed with uterine cervical dysplasia based on abnormal results in mass screening.
    Muramatsu T; Yoshitake T; Iida T; Yamashita E; Hirasawa T; Miyamoto T; Murakami M; Matsui N; Kajiwara H; Yasuda M; Osamura RY; Mikami M
    Tokai J Exp Clin Med; 2006 Dec; 31(4):141-5. PubMed ID: 21302243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS).
    Emerson RE; Puzanov A; Brunnemer C; Younger C; Cramer H
    Diagn Cytopathol; 2002 Sep; 27(3):153-7. PubMed ID: 12203862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance.
    Raab SS; Bishop NS; Zaleski MS
    Gynecol Oncol; 1999 Sep; 74(3):460-4. PubMed ID: 10479510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of moderate cervical dysplasia during long-term follow-up.
    Nasiell K; Nasiell M; Vaćlavinková V
    Obstet Gynecol; 1983 May; 61(5):609-14. PubMed ID: 6835614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conization for cervical dysplasia and carcinoma in situ: long term follow-up of 1013 women.
    Larsson G
    Ann Chir Gynaecol; 1981; 70(2):79-85. PubMed ID: 7316444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of cervical cytologic dysplasia.
    Jordan SW; Smith NL; Dike LS
    Acta Cytol; 1981; 25(3):237-44. PubMed ID: 6942614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Colposcopic verification of cytologic smears containing atypical squamous cells of undetermined significance].
    Pityński K; Basta A; Szczudrawa A; Strama M; Piwowarska E
    Przegl Lek; 1999; 56(1):37-40. PubMed ID: 10375923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the study of 96,483 cervical smears of young females up to 30 years of age. A review 5 years following the expansion of a preventive care program].
    Bierfreund B
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):804-7. PubMed ID: 3803874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pap smears with reactive cellular changes: a prospective study.
    Ding DC; Hsu S; Chen SS; Hsu YH
    J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HSV-2 antigen in carcinoma cervix and premalignant conditions by immuno-cytochemistry.
    Pandit AA; Khilnani PH; Powar H; Bhave GG; Chadda NO
    J Postgrad Med; 1990 Oct; 36(4):185-90. PubMed ID: 2132242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
    Abdul MA; Shittu SO; Randawa JA; Shehu MS
    Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.